Genzyme Corporation

(NASDAQ:GENZ)

66.87

-1.13 (-1.66%)

Nov 20 - Close

Open
68.13
High
69.73
Low
66.00
Vol.
1.42M
Mkt Cap
18.09B
52Wk High
83.97
52Wk Low
60.28
Avg. Vol.
3.39M
P/E (Trailing)
45.18
Beta
0.74
Short %
2.70%
Div. Yield
—

After-Hours 67.20 +0.33 (0.49%) Thu, 20 Nov 2008 5:30 PM

Company Profile

Genzyme Corporation

500 Kendall Street

Cambridge, MA 02142

United States - Map

Phone: (617) 252-7500

Fax: (617) 252-7600

Website: www.genzyme.com

State of incorporation: Massachusetts

CEO: Henri A. Termeer

Employees: 10,000

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Dev/mfr/mkt human health-care prods

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, diagnostic & predictive test

Recent news for GENZ

Recent opinions on GENZ

No recent Opinions for GENZ

Top members owning GENZ

Members owning GENZ also own

C (27.27%), MON (27.27%), CEDC (27.27%), JNJ (27.27%), FRE (18.18%)

Member sentiment: Neutral